Hoe much is the CAGR of artificial intelligence in diagnostics market?

The artificial intelligence in diagnostics market is expected to grow at a CAGR of 20.37% over forecast period 2025 to 2034. Read More

What is the current size of artificial intelligence in diagnostics market?

The artificial intelligence in diagnostics market size was valued at USD 1.61 billion in 2024. Read More

What are the factors driving the artificial intelligence in diagnostics market?

The introduction of AI platform is estimated to lift the clinical diagnosis growth by scaling up healthcare services across the globe. It is projected to deliver improved patient safety, outcome scrutiny, and data assortment. Progressions in data analytics is considered to upsurge the growth in the healthcare artificial intelligence industry during upcoming years. Read More

How much is the North America AI diagnostics market share?

North America led the Ai in diagnostics market with substantial share of revenue more than 58% in 2024. This is credited to escalating implementation of healthcare IT solutions in diagnosis, huge subsidy for improvement of AI-based diagnosis software and existence of well-organized healthcare sector. Read More

Which region hold maximum CAGR in artificial intelligence in diagnostics market?

However, Asia Pacific is considered to be most potential regional market for healthcare AI business. Healthcare AI in Asia Pacific is backed by expansions in biotechnology and pharmaceutical industry and rising R&D expenditure. Read More

Who are the key players in artificial intelligence in diagnostics market?

Different players contending in the market arena include Siemens Healthcare GmbH, GE Healthcare, Aidoc, Imagen Technologies, AliveCor, Zebra Medical, Vision, Vuno Inc., IDx Technologies Inc., Neural Analytics, Riverain Technologies and others. Read More

Which segment accounted for the largest artificial intelligence in diagnostics market share?

Software appeared as the prominent segment in the AI diagnostics market with a share of more than 46% in 2023. Read More

Artificial Intelligence in Diagnostics Market Size, Share, and Trends 2024 to 2034

The global artificial intelligence in diagnostics market size was accounted for USD 1.61 billion in 2024, grew to USD 1.94 billion in 2025 and is predicted to surpass around USD 10.28 billion by 2034, representing a healthy CAGR of 20.37% between 2025 and 2034. The North America artificial intelligence in diagnostics market size was calculated at USD 930 million in 2024 and is expected to grow at a fastest CAGR of 20.51% during the forecast year.

Last Updated : December 2024
Report Code : 1114
Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Artificial Intelligence in Diagnostics Market, By Component

7.1. Artificial Intelligence in Diagnostics Market, by Component Type, 2025-2034
7.1.1. Hardware
7.1.1.1. Market Revenue and Forecast (2022-2034)
7.1.2. Software
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Services
7.1.3.1. Market Revenue and Forecast (2022-2034)

Chapter 8. Global Artificial Intelligence in Diagnostics Market, By Diagnosis Type

8.1. Artificial Intelligence in Diagnostics Market, by Diagnosis Type, 2025-2034
8.1.1. Radiology
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Pathology
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Cardiology
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Oncology
8.1.4.1. Market Revenue and Forecast (2022-2034)
8.1.5. Neurology
8.1.5.1. Market Revenue and Forecast (2022-2034)
8.1.6. Chest and Lung
8.1.6.1. Market Revenue and Forecast (2022-2034)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2022-2034)

Chapter 9. Global Artificial Intelligence in Diagnostics Market, Regional Estimates and Trend Forecast

9.1. North America
9.1.1. Market Revenue and Forecast, by Component (2022-2034)
9.1.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Component (2022-2034)
9.1.3.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Component (2022-2034)
9.1.4.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Component (2022-2034)
9.2.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Component (2022-2034)
9.2.3.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Component (2022-2034)
9.2.4.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Component (2022-2034)
9.2.5.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Component (2022-2034)
9.2.6.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Component (2022-2034)
9.3.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Component (2022-2034)
9.3.3.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Component (2022-2034)
9.3.4.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Component (2022-2034)
9.3.5.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Component (2022-2034)
9.3.6.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Component (2022-2034)
9.4.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Component (2022-2034)
9.4.3.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Component (2022-2034)
9.4.4.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Component (2022-2034)
9.4.5.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Component (2022-2034)
9.4.6.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Component (2022-2034)
9.5.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Component (2022-2034)
9.5.3.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Component (2022-2034)
9.5.4.2. Market Revenue and Forecast, by Diagnosis Type (2022-2034)

Chapter 10. Company Profiles

10.1. Siemens Healthcare GmbH
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. GE Healthcare
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Aidoc
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Imagen Technologies
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. AliveCor
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Zebra Medical Vision
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Vuno Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. IDx Technologies Inc.
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Neural Analytics
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Riverain Technologies
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives

Chapter 11. Research Methodology

11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions

Chapter 12. Appendix

12.1. About Us
12.2. Glossary of Terms

We use cookies to improve your experience

Artificial Intelligence in Diagnostics Market Size to Hit USD 10.28 Bn by 2034

List of Contents